Efficient gram-scale synthesis and preclinical evaluation of an escin-derived therapeutic for ovarian cancer
{{output}}
Ovarian cancer is the most lethal gynecologic malignancy, characterized by a poor five-year survival rate for patients with advanced-stage disease. EV-S008, an escin derivative, exhibits potent anti-ovarian cancer activity; however, its preclinical development... ...
